Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.

Antimicrobial Agents and Chemotherapy
John A CrumpEmerging Infections Program FoodNet and NARMS Working Groups

Abstract

Patients with typhoid fever due to Salmonella enterica serotype Typhi strains for which fluoroquinolones MICs are elevated yet that are classified as susceptible by the current interpretive criteria of the Clinical and Laboratory Standards Institute may not respond adequately to fluoroquinolone therapy. Patients from seven U.S. states with invasive Salmonella serotype Typhi infection between 1999 and 2002 were enrolled in a multicenter retrospective cohort study. Patients infected with Salmonella serotype Typhi isolates with ciprofloxacin MICs of 0.12 to 1 microg/ml (decreased ciprofloxacin susceptibility but not resistant to ciprofloxacin [DCS]) were compared with patients infected with isolates with ciprofloxacin MICs <0.12 microg/ml for fever clearance time and treatment failure. Of 71 patients, 30 (43%) were female and 24 (34%) were infected with Salmonella serotype Typhi with DCS; the median age was 14 years (range, 1 to 51 years). Twenty-one (88%) of 24 isolates with DCS were resistant to nalidixic acid. The median antimicrobial-related fever clearance times in the DCS and non-DCS groups were 92 h (range, 21 to 373 h) and 72 h (range, 19 to 264 h) (P = 0.010), respectively, and the fluoroquinolone-related fever clearance ...Continue Reading

References

May 1, 1986·Reviews of Infectious Diseases·R Edelman, M M Levine
Sep 8, 1972·Nature·C K Paniker, K N Vimala
Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B RoweE J Threlfall
Sep 26, 1997·Antimicrobial Agents and Chemotherapy·V ZellerN J Moreau
Feb 7, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J WainC M Parry
May 1, 1999·Tropical Medicine & International Health : TM & IH·E T van den BerghM V Dolmans
May 20, 1999·Lancet·E J ThrelfallS Lacey
May 20, 2000·JAMA : the Journal of the American Medical Association·M L AckersE D Mintz
Jan 25, 2003·Antimicrobial Agents and Chemotherapy·Frank Møller AarestrupE John Threlfall
Jun 28, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A CrumpFrederick J Angulo
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ban Mishu AllosRobert V Tauxe
Mar 24, 2005·International Journal of Antimicrobial Agents·M Mushfequr RahmanM Atiqur Rahman
Sep 15, 2005·Annals of Tropical Paediatrics·Mandeep WaliaMani Kalaivani
Jun 29, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kathryn GayDavid C Hooper
Oct 4, 2006·Transactions of the Royal Society of Tropical Medicine and Hygiene·Fiona J CookeE John Threlfall

❮ Previous
Next ❯

Citations

Apr 10, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S HumeJ Torresi
Feb 13, 2010·Epidemiology and Infection·W H B DemczukUNKNOWN Canadian Public Health Laboratory Network
Nov 26, 2010·Médecine sciences : M/S·François-Xavier Weill
Dec 18, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John A Crump, Eric D Mintz
Aug 21, 2008·Foodborne Pathogens and Disease·Peter Gerner-Smidt, Jean M Whichard
Jul 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Romney M HumphriesJanet A Hindler
Jun 22, 2011·Antimicrobial Agents and Chemotherapy·Maria Sjölund-KarlssonJean M Whichard
May 23, 2012·Antimicrobial Agents and Chemotherapy·Matthew E FalagasKonstantinos Z Vardakas
Dec 2, 2009·Antimicrobial Agents and Chemotherapy·Hong Bin KimDavid C Hooper
Jan 5, 2011·Antimicrobial Agents and Chemotherapy·John A CrumpUNKNOWN Emerging Infections Program NARMS Working Group
Apr 14, 2010·Infection and Immunity·Helene L Andrews-PolymenisFerric C Fang
Jun 1, 2012·Journal of Clinical Microbiology·A TatavarthyP Amuso
Jun 6, 2009·BMJ : British Medical Journal·Durrane ThaverZulfiqar A Bhutta
Jul 14, 2011·Emerging Infectious Diseases·Felicita MedallaEsra J Barzilay
Jul 14, 2011·Emerging Infectious Diseases·Marie Accou-DemartinFrançois-Xavier Weill
Jan 5, 2011·Emerging Infectious Diseases·Manar Al-MashhadaniChristopher M Parry
Oct 12, 2010·Journal of Global Infectious Diseases·Malini Rajinder Capoor, Deepthi Nair
Feb 2, 2013·Journal of Clinical and Diagnostic Research : JCDR·Manish Chandey, A S Multani
Feb 12, 2014·BMC Infectious Diseases·Christopher M ParryStephen Baker
Feb 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emily LutterlohEric Mintz
Mar 8, 2013·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chia-Jie LeeCheng-Hsun Chiu
Nov 29, 2011·Travel Medicine and Infectious Disease·Flor M Sánchez-VargasOscar G Gómez-Duarte
Jun 18, 2011·The Medical Clinics of North America·Luke F ChenKeith S Kaye
Aug 21, 2010·Médecine et maladies infectieuses·V GaborieauB Marchou
Apr 13, 2010·Enfermedades infecciosas y microbiología clínica·Rafael Cantón
Dec 8, 2009·The Journal of Infection·Tristan W ClarkIain Stephenson
Nov 17, 2009·Infectious Disease Clinics of North America·Luke F ChenKeith S Kaye
Jul 30, 2014·Annals of the New York Academy of Sciences·Aparna TatavarthyPhilip T Amuso
Jun 10, 2014·La Revue de médecine interne·V de Lastours, B Fantin
Aug 19, 2015·Enfermedades infecciosas y microbiología clínica·Ana González-TorralbaJuan-Ignacio Alós
Apr 29, 2015·Vaccine·Samuel KariukiChristopher M Parry
May 17, 2015·Transactions of the Royal Society of Tropical Medicine and Hygiene·Richa MisraMalay Ghar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
John A CrumpFrederick J Angulo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J WainChristopher M Parry
© 2021 Meta ULC. All rights reserved